MedTrace Logo

Comparing the Effectiveness of AI Chatbot with That of Telephone Hotline

NCT06621134 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2024-10-01

No results posted yet for this study

Summary

The COVID-19 pandemic has significantly impacted the wellbeing of people in Hong Kong, leading to social distancing policies and changes in healthcare service utilization. School closures and remote work have increased stress levels for parents and children. Vulnerable populations, such as low-income families and children with special needs, are at higher risk of maltreatment and mental health issues. Parental burnout has become a concern as parents juggle work, childcare, and education responsibilities. There is a need for research on the physical and mental health effects of COVID-19 on families and the potential role of AI in addressing these challenges. AI, particularly chatbots, can provide accessible healthcare information and support, aiding in early diagnosis and treatment. AI chatbots offer timely responses, accurate information, and continuous availability, making them valuable tools for remote health assistance. While AI chatbots are not without limitations, further research can help integrate them more effectively into healthcare services.

Conditions

  • Telephone Hotlines
  • AI Chatbot

Interventions

OTHER

AI Chatbot

Participants will be required to provide consent for randomization when they first access our system. Users can ask questions covered by the question bank, as well as specific questions not covered by the bank, through an AI chatbox. The aim is to understand the significant difference between using AI chatbots and telephone hotlines to assist parents, as well as the effectiveness of AI chatbots compared to telephone hotlines.

OTHER

Telephone hotline

Participants will be asked to consent to randomization on their first access to our system. Users ask questions covered by the question bank and specific questions not covered by the question through a telephone hotline.

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-03
Primary Completion
2024-09-04
Completion
2024-09-05

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06621134 on ClinicalTrials.gov